Target intelligence / Profile preview

Lipopolysaccharide lipid A (Lipid A)

Target
Lipid A
Molecular classification
Glycolipid, Endotoxin, Bacterial cell wall component
01

Overview

Lipopolysaccharide lipid A is the highly conserved, hydrophobic anchor of lipopolysaccharide (LPS) located in the outer leaflet of the outer membrane of Gram-negative bacteria. Often referred to as endotoxin, it is the primary bioactive component responsible for the potent inflammatory response associated with Gram-negative infections (Raetz & Whitfield, 2002, Annu Rev Biochem). Lipid A is recognized by the human innate immune system through the Toll-like receptor 4 (TLR4) and myeloid differentiation factor 2 (MD-2) complex, which triggers the release of pro-inflammatory cytokines (Park et al., 2009, Nature). While essential for bacterial viability and membrane stability, Lipid A serves as a critical therapeutic target for cationic antimicrobial peptides like polymyxins, which bind to its phosphate groups to disrupt the bacterial cell wall (Poirel et al., 2017, Clin Microbiol Rev). Furthermore, Lipid A is a focal point in the development of anti-sepsis therapies aimed at neutralizing its activity or blocking its interaction with host receptors to prevent septic shock (Hotchkiss et al., 2016, Nat Rev Dis Primers). Its synthesis and transport from the cytoplasmic membrane to the outer membrane are also targets for novel antibiotic development.

Other names
EndotoxinLipid A component of LPSLipid A moietyLPS Lipid A
02

Mechanism of action

Binding to the lipid A moiety of lipopolysaccharide to disrupt the bacterial outer membrane; competitive antagonism of the TLR4/MD-2 receptor complex to prevent endotoxin-induced cytokine release.

03

Biological functions

Structural integrity of the outer membraneInnate immune system activationPermeability barrier maintenanceEndotoxin-mediated signaling
04

Disease associations

InfectionSepsisSeptic shockSystemic inflammatory response syndrome (SIRS)
05

Safety considerations

NephrotoxicityNeurotoxicityJarisch-Herxheimer reactionEndotoxin release during bacterial lysisRisk of systemic inflammatory over-activation
06

Interacting drugs

Polymyxin B

4 more in the full profile.

07

Biomarkers

Endotoxin activity assay (EAA)ProcalcitoninC-reactive proteinInterleukin-6 (IL-6)

Beyond the preview

Go deeper on Lipopolysaccharide lipid A (Lipid A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipopolysaccharide lipid A (Lipid A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call